GGrantIndex
← Leaderboards

Karsten Gronert

Brigham And Women'S Hospital

$6,688,446
Attributed
$8,289,316
Total exposure
7
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $686.6K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$8,289,316 · 7

By mechanism

R01$7,281,780 · 4
P30$597,708 · 1
K01$367,200 · 1
F32$42,628 · 1

Top collaborators

Most similar at Brigham And Women'S Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Receptor

Research focus

ReceptorPhenotypeLipoxin A4ResponseLipid MediatorAffectInflammatoryLipidsPathway InteractionsCellsTissuesInflammationEicosanoidsInjuryLox GeneEtiologyMediatingRegulationRetinaPathogenesisLeadEpithelialCorneaMediator Of Activation Protein

Grant awards (27)

Bioinformatics$199,236
P30 · FY2025 · EY · contact PI
Homeostatic Role and Therapeutic Potential of the Neuroprotective Retinal Lipoxin Circuit$487,337
R01 · FY2024 · EY · contact PI
Bioinformatics$199,236
P30 · FY2024 · EY · contact PI
Homeostatic Role and Therapeutic Potential of the Neuroprotective Retinal Lipoxin Circuit$487,337
R01 · FY2023 · EY · contact PI
Bioinformatics$199,236
P30 · FY2023 · EY · contact PI
Homeostatic Role and Therapeutic Potential of the Neuroprotective Retinal Lipoxin Circuit$472,715
R01 · FY2022 · EY · contact PI
Homeostatic Role and Therapeutic Potential of the Neuroprotective Retinal Lipoxin Circuit$463,917
R01 · FY2021 · EY · contact PI
Homeostatic Role and Therapeutic Potential of the Neuroprotective Retinal Lipoxin Circuit$489,999
R01 · FY2020 · EY · contact PI
Regulatory Tissue Polymorphonuclear Leukocytes Determinants of Ocular Immune Responses$379,995
R01 · FY2019 · EY · contact PI
Regulatory Tissue Polymorphonuclear Leukocytes Determinants of Ocular Immune Responses$380,921
R01 · FY2018 · EY · contact PI
Regulatory Tissue Polymorphonuclear Leukocytes Determinants of Ocular Immune Responses$381,779
R01 · FY2017 · EY · contact PI
Regulatory Tissue Polymorphonuclear Leukocytes Determinants of Ocular Immune Responses$382,573
R01 · FY2016 · EY · contact PI
Sex-specific Regulation of Acute Inflammation and Resolution$367,038
R01 · FY2015 · EY · contact PI
Sex-specific Regulation of Acute Inflammation and Resolution$367,861
R01 · FY2014 · EY · contact PI
Sex-specific Regulation of Acute Inflammation and Resolution$357,323
R01 · FY2013 · EY · contact PI
Sex-specific Regulation of Acute Inflammation and Resolution$376,823
R01 · FY2012 · EY · contact PI
Protective Lipid Circuits in Corneal Injury and Disease$372,634
R01 · FY2009 · EY · contact PI
Protective Lipid Circuits in Corneal Injury and Disease$363,992
R01 · FY2008 · EY · contact PI
Protective Lipid Circuits in Corneal Injury and Disease$300,079
R01 · FY2007 · EY · contact PI
Protective Lipid Circuits in Corneal Injury and Disease$78,622
R01 · FY2007 · EY · contact PI
Protective Lipid Circuits in Corneal Injury and Disease$380,835
R01 · FY2006 · EY · contact PI
Protective Lipid Circuits in Corneal Injury and Disease$390,000
R01 · FY2005 · EY
Anti-inflammatory lipids in acute mucosal inflammation$133,920
K01 · FY2004 · DK
Anti-inflammatory lipids in acute mucosal inflammation$68,040
K01 · FY2003 · DK
Anti-inflammatory lipids in acute mucosal inflammation$66,960
K01 · FY2003 · DK
Anti-inflammatory lipids in acute mucosal inflammation$98,280
K01 · FY2002 · DK
ANTIINFLAMMATORY PHENOTYPE OF NEUTROPHILS$42,628
F32 · FY2000 · AI